Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

University of California (UC) Davis

Status: Enrolling

Conditions: Sugammadex

Treatments: Device: Quantitative Neuromuscular Function Monitoring

Study type: Observational

Funder types: Other

Identifiers

NCT05886218

2004503

Details and patient eligibility

About

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

Enrollment: 215 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age greater than 18 years
• scheduled for an elective laparoscopic gastric bypass procedure

Exclusion criteria

• age less than 18 years
• pregnancy
• prisoners
• significant co-existing lung disease including asthma or chronic obstructive pulmonary disease (COPD) requiring regular medication
• patients who require supplemental oxygen pre-operatively to maintain a hemoglobin saturation (SpO2>98%)